Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569212
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-19
Brief Title:
Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage BADCATS
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage BADCATS
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BADCATS
Brief Summary:
To determine the effect of early metoprolol administration after non-traumatic subarachnoid hemorrhage SAH
Detailed Description:
To determine the effect of early metoprolol administration after non-traumatic subarachnoid hemorrhage SAH on the brain and cardiac tissue damage and inflammation we will conduct a pilot randomized controlled trial comparing 1 sympathetic nervous system SNS activation 2 cardiac rhythm abnormalities 3 biomarkers of brain and cardiac tissue damage and 4 and neutrophil activity in patients receiving metoprolol n10 or placebo n10 for the first 72-hours after SAH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None